boston scientific corp (BSX:New York)
Transactions by BOSTON SCIENTIFIC CORP (BSX) in the last 6 months
Sensible Medical Innovation Ltd announced that it has received $20 million in third round funding on November 11, 2013. The round was led by new investor Boston Scientific Corporation with participation from other new investor LongTec Medical Technology Co., Ltd. along with returning investors SCP Vitalife II, L.P., a fund managed by SCP Vitalife and Genesis Partners.
Genesis Partners Ltd.
LongTech Medical Technology Co., Ltd.
SCP Vitalife II, L.P.
SetPoint Medical Corporation announced that it will receive $30,607,151 in an equity round of funding on August 2, 2013. The round will see participation from seven investors. The securities will be issued pursuant to exemption provided under Regulation D.
On August 8, 2013, the company announced that it has received $27,000,000 in its fourth round of funding from new investors Covidien Ventures, Boston Scientific Corporation, Action Potential Venture Capital Limited, ...
Boston Scientific Corporation
Covidien Ventures Ltd.
Foundation Medical Partners
GlaxoSmithKline plc, Investment Arm
Topspin Partners LP
|Becton Dickinson and Co||$105.00 USD||-0.64|
|Olympus Corp||¥3,220 JPY||-80.00|
|Smith & Nephew PLC||835.00 GBp||-5.50|
|St Jude Medical Inc||$58.01 USD||-0.14|
|Zimmer Holdings Inc||$90.00 USD||-0.34|
|View Industry Companies|
Post a JobJobs
- Marlborough, MA | Boston ScientificPosted: Dec 07
- Marlborough, MA | Boston ScientificPosted: Dec 06
- Valencia, CA | Boston ScientificPosted: Dec 12
- Fremont, CA | Boston ScientificPosted: Nov 28